Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome

NCT04056169 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.

NCT NCT04056169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04056169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
Lead sponsor
Yuhan Corporation
Phase
Phase 4
Overall status
Completed
Start date
June 29, 2017
Completion date
July 23, 2019
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, carotid atherosclerotic plaque with inflammation